The Patent Finder

Hormos Nutraceutical Oy Ltd.

Also on record
Records under this name other than patents Hormos Nutraceutical Oy Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Hormos Nutraceutical Oy Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,008,666Method of inhibiting overactivity of phagocytes or lymphocytes in an individual
Term ended
Term ended Nov 26, 2021 · USPTO record
Term endedTerm ended Nov 26, 2021USPTO record
US 7,005,447Food product comprising hydroxymatairesinol
Term ended
Term ended Feb 3, 2020 · USPTO record
Term endedTerm ended Feb 3, 2020USPTO record
US 6,689,809Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol
Term ended
Ended no later than Jul 9, 2019 · USPTO record
Term endedEnded no later than Jul 9, 2019USPTO record
US 6,451,849Use of Hydroxymatairesinol for Prevention of Cancers, Non-Cancer, Hormone Dependent Diseases and Cardiovascular Diseases by Hydroxymatairesinol, and a Pharmaceutical Preparation, Food Additive and Food Product Comprising Hydroxymatairesinol
Term ended
Term ended Mar 30, 2019 · USPTO record
Term endedTerm ended Mar 30, 2019USPTO record
US 6,271,257Decreasing the intracellular level of .beta.-catenin by administering hydroxymatairesinol
Lapsed on the fee record
Ended Aug 7, 2013 · USPTO record
Lapsed on the fee recordEnded Aug 7, 2013USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited